Chlamydia IgG ELISA Kit for Human

Intended Uses: The Chlamydia Pneumoniae IgA ELISA kit is intended for the detection of IgA antibody to C. Pneumoniae in human serum or plasma. For research use only.

Principle of the Assay: Diluted serum is added to wells coated with purified antigen. IgA specific antibody, if present, binds to the antigen. All unbound materials are washed away and the enzyme conjugate is added to bind to the antibody-antigen complex, if present. Excess enzyme conjugate is washed off and substrate is added. The plate is incubated to allow the hydrolysis of the substrate by the enzyme. The intensity of the color generated is proportional to the amount of IgA specific antibody in the unknown.

Small volumes of Chlamydia IgG elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS494198 is a ready-to-use microwell, strip-or-full plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the Chlamydia IgG, ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing Chlamydia IgG. The ELISA analytical biochemical technique of the MBS494198 kit is based on Chlamydia IgG antibody-Chlamydia IgG antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect Chlamydia IgG antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, Chlamydia IgG. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).